Life Sciences

Japan has one of the world’s fastest growing elderly populations, driving growth in the huge Life Sciences market. In 2010, almost a quarter of Japan’s 127 million people were over 65. And this is predicted to increase to over 30% by 2025 and to 40% by 2055. Japanese society is therefore facing an increasing number of chronic and long-term diseases. After the US, Japan has the second largest healthcare, pharmaceutical and medical devices markets in the world. Total medical expenditure is over £250 billion a year and the Japanese pharmaceutical market is bigger than both France and Germany's combined.

For the healthcare market, unique, sophisticated, and highly technical products are sought to assist elderly people, ranging from healthy elderly people to those with disabilities. For the medical devices market, opportunities exist with advanced and innovative products for exports of finished products, joint R&D and technology licensing-out. In pharmaceuticals, the demand for joint development, outsourcing of R&D, clinical trials and regulatory affairs to Europe continues to increase. For more see UK Trade & Investment's Introduction to Healthcare & Medical Devices in Japan and Introduction to Biotechnology & Pharmaceuticals in Japan.

Five Trends In Japan That Matter To You

Five Trends In Japan That Matter To You - Export to Japan

The UK Trade & Investment team in Japan has pulled together the five trends that matter right now to businesses in Japan.  These include a shift towards low carbon, a globalising business environment, Japanese consumer appreciation of quality, authenticity & originality, an ageing society, and the removal of trade barriers.

Industry Insight: Chemicals Sector In Japan

Industry Insight: Chemicals Sector In Japan - Export to Japan

10 May 2014

Chemical companies here have been shifting from manufacturing commodity products to high value-added specialty chemicals, in particular for the booming pharmaceutical sector, which offers opportunities for British firms in the outsourced manufacturing of active ingredients and intermediaries, according to the London-based Chemical Industries Association. 

Doing Business with Daiichi Sankyo Report

Doing Business with Daiichi Sankyo Report - Export to Japan

An essential guide for companies in the Life Sciences sector seeking to expand into the Japanese market. This downloadable report will ensure you have the information you need to take advantage of future collaboration and research opportunities with Daiichi Sankyo.

Japan Time
Dec 04
UK Time
Dec 04

Innovation and Partnering with Eisai: Webinar

Innovation and Partnering with Eisai: Webinar - Export to Japan
4 December 2014
4 December 2014
9:30am | UK Time
6:30pm | Japan Time

Join this free webinar to learn from top performers in the Japanese pharmaceutical market, Eisai Co., Ltd., about open innovation and partnering strategies for future collaboration.